These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 30767504)

  • 21. Development and validation of an artificial neural network algorithm to predict mortality and admission to hospital for heart failure after myocardial infarction: a nationwide population-based study.
    Mohammad MA; Olesen KKW; Koul S; Gale CP; Rylance R; Jernberg T; Baron T; Spaak J; James S; Lindahl B; Maeng M; Erlinge D
    Lancet Digit Health; 2022 Jan; 4(1):e37-e45. PubMed ID: 34952674
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Benefit of Vasodilating β-Blockers in Patients With Acute Myocardial Infarction After Percutaneous Coronary Intervention: Nationwide Multicenter Cohort Study.
    Chung J; Han JK; Kim YJ; Kim CJ; Ahn Y; Chan Cho M; Chae SC; Chae IH; Chae JK; Seong IW; Yang HM; Park KW; Kang HJ; Koo BK; Jeong MH; Kim HS;
    J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29066446
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcomes 1 year after thrombus aspiration for myocardial infarction.
    Lagerqvist B; Fröbert O; Olivecrona GK; Gudnason T; Maeng M; Alström P; Andersson J; Calais F; Carlsson J; Collste O; Götberg M; Hårdhammar P; Ioanes D; Kallryd A; Linder R; Lundin A; Odenstedt J; Omerovic E; Puskar V; Tödt T; Zelleroth E; Östlund O; James SK
    N Engl J Med; 2014 Sep; 371(12):1111-20. PubMed ID: 25176395
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Irbesartan in patients with heart failure and preserved ejection fraction.
    Massie BM; Carson PE; McMurray JJ; Komajda M; McKelvie R; Zile MR; Anderson S; Donovan M; Iverson E; Staiger C; Ptaszynska A;
    N Engl J Med; 2008 Dec; 359(23):2456-67. PubMed ID: 19001508
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Eplerenone in patients with systolic heart failure and mild symptoms.
    Zannad F; McMurray JJ; Krum H; van Veldhuisen DJ; Swedberg K; Shi H; Vincent J; Pocock SJ; Pitt B;
    N Engl J Med; 2011 Jan; 364(1):11-21. PubMed ID: 21073363
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of Ischemic Postconditioning During Primary Percutaneous Coronary Intervention for Patients With ST-Segment Elevation Myocardial Infarction: A Randomized Clinical Trial.
    Engstrøm T; Kelbæk H; Helqvist S; Høfsten DE; Kløvgaard L; Clemmensen P; Holmvang L; Jørgensen E; Pedersen F; Saunamaki K; Ravkilde J; Tilsted HH; Villadsen A; Aarøe J; Jensen SE; Raungaard B; Bøtker HE; Terkelsen CJ; Maeng M; Kaltoft A; Krusell LR; Jensen LO; Veien KT; Kofoed KF; Torp-Pedersen C; Kyhl K; Nepper-Christensen L; Treiman M; Vejlstrup N; Ahtarovski K; Lønborg J; Køber L;
    JAMA Cardiol; 2017 May; 2(5):490-497. PubMed ID: 28249094
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Osteoprotegerin predicts progression of chronic heart failure: results from CORONA.
    Ueland T; Dahl CP; Kjekshus J; Hulthe J; Böhm M; Mach F; Goudev A; Lindberg M; Wikstrand J; Aukrust P; Gullestad L
    Circ Heart Fail; 2011 Mar; 4(2):145-52. PubMed ID: 21216833
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Avoiding Routine Oxygen Therapy in Patients With Myocardial Infarction Saves Significant Expenditure for the Health Care System-Insights From the Randomized DETO2X-AMI Trial.
    Hofmann R; Abebe TB; Herlitz J; James SK; Erlinge D; Alfredsson J; Jernberg T; Kellerth T; Ravn-Fischer A; Lindahl B; Langenskiöld S;
    Front Public Health; 2021; 9():711222. PubMed ID: 35096723
    [No Abstract]   [Full Text] [Related]  

  • 29. Extracellular cardiac matrix biomarkers in patients with acute myocardial infarction complicated by left ventricular dysfunction and heart failure: insights from the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS) study.
    Iraqi W; Rossignol P; Angioi M; Fay R; Nuée J; Ketelslegers JM; Vincent J; Pitt B; Zannad F
    Circulation; 2009 May; 119(18):2471-9. PubMed ID: 19398668
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The early diastolic myocardial velocity: a marker of increased risk in patients with coronary heart disease.
    Johnson J; Manouras A; Bergholm F; Brodin LÅ; Agewall S; Henareh L
    Clin Physiol Funct Imaging; 2014 Sep; 34(5):389-96. PubMed ID: 24438358
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of acarbose on cardiovascular and diabetes outcomes in patients with coronary heart disease and impaired glucose tolerance (ACE): a randomised, double-blind, placebo-controlled trial.
    Holman RR; Coleman RL; Chan JCN; Chiasson JL; Feng H; Ge J; Gerstein HC; Gray R; Huo Y; Lang Z; McMurray JJ; Rydén L; Schröder S; Sun Y; Theodorakis MJ; Tendera M; Tucker L; Tuomilehto J; Wei Y; Yang W; Wang D; Hu D; Pan C;
    Lancet Diabetes Endocrinol; 2017 Nov; 5(11):877-886. PubMed ID: 28917545
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Global Longitudinal Strain by Echocardiography Predicts Long-Term Risk of Cardiovascular Morbidity and Mortality in a Low-Risk General Population: The Copenhagen City Heart Study.
    Biering-Sørensen T; Biering-Sørensen SR; Olsen FJ; Sengeløv M; Jørgensen PG; Mogelvang R; Shah AM; Jensen JS
    Circ Cardiovasc Imaging; 2017 Mar; 10(3):. PubMed ID: 28264868
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Blood lactate is a predictor of short-term mortality in patients with myocardial infarction complicated by heart failure but without cardiogenic shock.
    Gjesdal G; Braun OÖ; Smith JG; Scherstén F; Tydén P
    BMC Cardiovasc Disord; 2018 Jan; 18(1):8. PubMed ID: 29347907
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic effect of high-sensitive troponin T assessment in elderly patients with chronic heart failure: results from the CORONA trial.
    Gravning J; Askevold ET; Nymo SH; Ueland T; Wikstrand J; McMurray JJ; Aukrust P; Gullestad L; Kjekshus J;
    Circ Heart Fail; 2014 Jan; 7(1):96-103. PubMed ID: 24284025
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of Cardiac Resynchronization Therapy on Cardiac Remodeling and Contractile Function: Results From Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction (REVERSE).
    St John Sutton M; Cerkvenik J; Borlaug BA; Daubert C; Gold MR; Ghio S; Chirinos JA; Linde C; Ky B
    J Am Heart Assoc; 2015 Sep; 4(9):e002054. PubMed ID: 26363005
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic Impact of Diabetes and Prediabetes on Survival Outcomes in Patients With Chronic Heart Failure: A Post-Hoc Analysis of the GISSI-HF (Gruppo Italiano per lo Studio della Sopravvivenza nella Insufficienza Cardiaca-Heart Failure) Trial.
    Dauriz M; Targher G; Temporelli PL; Lucci D; Gonzini L; Nicolosi GL; Marchioli R; Tognoni G; Latini R; Cosmi F; Tavazzi L; Maggioni AP;
    J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28679559
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Congestive heart failure with preserved left ventricular systolic function after acute myocardial infarction: clinical and prognostic implications.
    Møller JE; Brendorp B; Ottesen M; Køber L; Egstrup K; Poulsen SH; Torp-Pedersen C;
    Eur J Heart Fail; 2003 Dec; 5(6):811-9. PubMed ID: 14675860
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Atrial fibrillation in patients hospitalized with acute myocardial infarction: analysis of the china acute myocardial infarction (CAMI) registry.
    Dai Y; Yang J; Gao Z; Xu H; Sun Y; Wu Y; Gao X; Li W; Wang Y; Gao R; Yang Y;
    BMC Cardiovasc Disord; 2017 Jan; 17(1):2. PubMed ID: 28052755
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sex Differences in Long-Term Outcomes With Cardiac Resynchronization Therapy in Mild Heart Failure Patients With Left Bundle Branch Block.
    Biton Y; Zareba W; Goldenberg I; Klein H; McNitt S; Polonsky B; Moss AJ; Kutyifa V;
    J Am Heart Assoc; 2015 Jun; 4(7):. PubMed ID: 26124205
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mortality and morbidity remain high despite captopril and/or Valsartan therapy in elderly patients with left ventricular systolic dysfunction, heart failure, or both after acute myocardial infarction: results from the Valsartan in Acute Myocardial Infarction Trial (VALIANT).
    White HD; Aylward PE; Huang Z; Dalby AJ; Weaver WD; Barvik S; Marin-Neto JA; Murin J; Nordlander RO; van Gilst WH; Zannad F; McMurray JJ; Califf RM; Pfeffer MA;
    Circulation; 2005 Nov; 112(22):3391-9. PubMed ID: 16301343
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.